C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Clinical trial NCT07037277 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07037277
Sponsor: Atea Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HEPATITIS C VIRUS CHRONIC INFECTION Hepatitis C, Chronic Hepatitis C Virus Infection Hepatitis C

Start date: 2025-06-02
Primary completion: 2026-12-01
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.